» Articles » PMID: 36226538

Iron Metabolism, Ferroptosis, and LncRNA in Cancer: Knowns and Unknowns

Overview
Date 2022 Oct 13
PMID 36226538
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer cells undergo substantial metabolic alterations to sustain increased energy supply and uncontrolled proliferation. As an essential trace element, iron is vital for many biological processes. Evidence has revealed that cancer cells deploy various mechanisms to elevate the cellular iron concentration to accelerate proliferation. Ferroptosis, a form of cell death caused by iron-catalyzed excessive peroxidation of polyunsaturated fatty acids (PUFAs), is a promising therapeutic target for therapy-resistant cancers. Previous studies have reported that long noncoding RNA (lncRNA) is a group of critical regulators involved in modulating cell metabolism, proliferation, apoptosis, and ferroptosis. In this review, we summarize the associations among iron metabolism, ferroptosis, and ferroptosis-related lncRNA in tumorigenesis. This information will help deepen understanding of the role of lncRNA in iron metabolism and raise the possibility of targeting lncRNA and ferroptosis in cancer combination therapy.

Citing Articles

A novel defined risk signature of ferroptosis-related lncRNAs for predicting prognosis, immune infiltration, and chemotherapy response in multiple myeloma.

Yu W, Jing Z, Tang J, Chen J Discov Oncol. 2025; 16(1):160.

PMID: 39934434 PMC: 11813854. DOI: 10.1007/s12672-025-01947-z.


Ferroptosis Plays a Pivotal Role in Activating and Modulating Specific Intracellular Signaling Pathways Integrated into the Therapeutic Management of Colorectal Cancer.

Monemi M, Ahmed H, Kareem R, Taher W, Alwan M, Jawad M Int J Mol Cell Med. 2025; 13(4):374-386.

PMID: 39895914 PMC: 11786127. DOI: 10.22088/IJMCM.BUMS.13.4.374.


The Impact of Iron on Cancer-Related Immune Functions in Oncology: Molecular Mechanisms and Clinical Evidence.

Badran O, Cohen I, Bar-Sela G Cancers (Basel). 2025; 16(24.

PMID: 39766056 PMC: 11674619. DOI: 10.3390/cancers16244156.


Unveiling the Network regulatory mechanism of ncRNAs on the Ferroptosis Pathway: Implications for Preeclampsia.

Zhang Y, Zhang J, Chen S, Li M, Yang J, Tan J Int J Womens Health. 2024; 16:1633-1651.

PMID: 39372667 PMC: 11451465. DOI: 10.2147/IJWH.S485653.


The evolving process of ferroptosis in thyroid cancer: Novel mechanisms and opportunities.

Yin L, Luo X, Zhang X, Cheng B J Cell Mol Med. 2024; 28(16):e18587.

PMID: 39163517 PMC: 11335058. DOI: 10.1111/jcmm.18587.


References
1.
Osborne N, Gurrin L, Allen K, Constantine C, Delatycki M, McLaren C . HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology. 2010; 51(4):1311-8. PMC: 3815603. DOI: 10.1002/hep.23448. View

2.
Muto Y, Moroishi T, Ichihara K, Nishiyama M, Shimizu H, Eguchi H . Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis. J Exp Med. 2019; 216(4):950-965. PMC: 6446870. DOI: 10.1084/jem.20180900. View

3.
Xue X, Bredell B, Anderson E, Martin A, Mays C, Nagao-Kitamoto H . Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancer. Proc Natl Acad Sci U S A. 2017; 114(45):E9608-E9617. PMC: 5692584. DOI: 10.1073/pnas.1712946114. View

4.
Netz D, Stith C, Stumpfig M, Kopf G, Vogel D, Genau H . Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexes. Nat Chem Biol. 2011; 8(1):125-32. PMC: 3241888. DOI: 10.1038/nchembio.721. View

5.
Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View